Cargando…
The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
Dopaminergic (DA) cell replacement therapies are a promising experimental treatment for Parkinson’s disease (PD) and a number of different types of DA cell-based therapies have already been trialled in patients. To date, the most successful have been allotransplants of foetal ventral midbrain but ev...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Portland Press Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438115/ https://www.ncbi.nlm.nih.gov/pubmed/34552761 http://dx.doi.org/10.1042/NS20200083 |